Pfizer on Monday announced that its COVID-19 vaccine has proven effective in over 90% of previously uninfected people, and added that it could have 50 million doses available by year-end.
Axios Re:Cap talks to Pfizer CEO Albert Bourla about vaccine data, distribution, politics, and how he reacted upon receiving the news.
- Pfizer expects to release safety data next week.
- It plans to let public health officials, in the U.S. and other countries, determine who receives initial doses.
- Once Phase 3 trials are completed and analyzed, Pfizer will release its data for peer-reviewed publication.
- Pfizer did not accept government money for development, in order to better "liberate our scientists" and to "keep Pfizer out of politics."
- Pfizer's independent vaccine advisory committee began receiving data last Thursday or Friday, and met Sunday at 11am. Bourla was informed of the results around 2pm, and says that had the data been available before the election, he would have released it before the election.